Pfizer Inc reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans in the wake of its recent failed efforts to purchase rival British drugmaker AstraZeneca Plc.The largest U.S. drugmaker on Tuesday said it had earned $2.67 billion, or 42 cents per share, in the third quarter. That compared with $2.59 billion, or 39 cents per share, a year earlier, when it took charges for restructurings, asset writedowns and other costs.Excluding special items, Pfizer earned 57 cents per share. Analysts on average expected 55 cents, according to Thomson Reuters I/B/E/S.Sales fell 2 percent to $12.36 billion, hurt by generic competition and the expiration of a longstanding deal with Amgen Inc to co-market its Enbrel arthritis drug. But they topped Wall Street expectations of $12.24 billion.
Amgen Inc. is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics. Shares of AMGN traded higher by 0.64% or $0.94/share to $148.20. In the past year, the shares have traded as low as $108.20 and as high as $148.47. On average, 3734380 shares of AMGN exchange hands on a given day and today's volume is recorded at 4173141.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN traded higher by 0.91% or $0.64/share to $70.76. In the past year, the shares have traded as low as $52.08 and as high as $82.68. On average, 2472340 shares of AZN exchange hands on a given day and today's volume is recorded at 1181188.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 0.27% or $-0.08/share to $29.03. In the past year, the shares have traded as low as $27.51 and as high as $32.96. On average, 25288500 shares of PFE exchange hands on a given day and today's volume is recorded at 22986816.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.43% or $0.16/share to $37.11. In the past year, the shares have traded as low as $33.21 and as high as $38.73. On average, 759628 shares of TRI exchange hands on a given day and today's volume is recorded at 668419.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.51% or $0.21/share to $41.70. In the past year, the shares have traded as low as $36.86 and as high as $42.10. On average, 727186 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 502230.
Source
